Read more from AP News
Two pharmaceutical companies, Hikma Pharmaceuticals and Fresenius Kabi USA, have objected to legislative efforts to expand the secrecy surrounding the source of Arkansas’ lethal injection drugs, saying the proposal would hamper their ability to ensure their products aren’t being used for executions.
Both companies oppose the use of their drugs in executions, and have put controls in place to ensure they’re not used for capital punishment.
“We are deeply concerned with efforts by any state to obscure or hide the source of products for lethal injection,” Brooke Clarke, Hikma’s vice president for global corporate affairs, said in a letter to House leaders. “It is imperative that we are not impeded from protecting patient health and upholding the protocols we have put in place to monitor the integrity of our products and supply chain.”